as on February 7, 2026 at 7:43 am IST
Day's Low
Day's High
11.59%
Downside
4.27%
Upside
52 Week's Low
52 Week's High
16.46%
Downside
145.79%
Upside
Check Apimeds Pharmaceuticals Us market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$24.3M
EPS (TTM)
0Dividend Yield
0.00%
PE Ratio (TTM)
0PEG Ratio
0Return On Equity TTM
0.00%
Compare market cap, revenue, PE, and other key metrics of Apimeds Pharmaceuticals Us with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| NA | $24.3M | NA | NA | 0.00% | |
| NA | $14.4B | NA | NA | 0.00% | |
| BUY | $21.6B | NA | 18.08 | 40.65% | |
| BUY | $46.2B | NA | 22.54 | 13.81% | |
| HOLD | $15.2B | -18.52% | -21.95 | -26.13% |
Search interest for Apimeds Pharmaceuticals Us Stock has increased by 133% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:133% versus previous 30 day period
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
All numbers in Millions USD
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
Price Dip
![]()
In the last 7 days, APUS stock has moved down by -12.4%
| Organisation | Apimeds Pharmaceuticals Us |
| Headquarters | B4-204A5, Business Centre 04, Ras Al Khaimah, United Arab Emirates |
| CEO | Dr. Vinod Menon |
| E-voting on shares | Click here to vote |
Name | Title |
|---|---|
Dr. Vinod Menon | Chief Executive Officer |
Captain Sandeep Yadav | Chief Operating Officer |
Mr. Amardeep Singh | Chief Technology Officer |
Apimeds Pharmaceuticals Us share price today is $1.64 as on at the close of the market. Apimeds Pharmaceuticals Us share today touched a day high of $1.71 and a low of $1.45.
Apimeds Pharmaceuticals Us share touched a 52 week high of $4.03 on and a 52 week low of $1.37 on . Apimeds Pharmaceuticals Us stock price today i.e. is closed at $1.64,which is 59.32% down from its 52 week high and 19.71% up from its 52 week low.
Apimeds Pharmaceuticals Us market capitalisation is $0.00T as on .
Indian investors can start investing in Apimeds Pharmaceuticals Us (APUS) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Apimeds Pharmaceuticals Us stock (as per the Rupee-Dollar exchange rate as on ).
Based on Apimeds Pharmaceuticals Us share’s latest price of $1.64 as on February 7, 2026 at 2:13 am IST, you will get 6.0976 shares of Apimeds Pharmaceuticals Us. Learn more about
fractional shares .